Details for New Drug Application (NDA): 021175
✉ Email this page to a colleague
NDA 021175 describes ATNAA, which is a drug marketed by Us Army and is included in one NDA. It is available from one supplier. Additional details are available on the ATNAA profile page.
The generic ingredient in ATNAA is atropine; pralidoxime chloride. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine; pralidoxime chloride profile page.
The generic ingredient in ATNAA is atropine; pralidoxime chloride. There are twenty-three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the atropine; pralidoxime chloride profile page.
Summary for 021175
| Tradename: | ATNAA |
| Applicant: | Us Army |
| Ingredient: | atropine; pralidoxime chloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 021175
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ATNAA | atropine; pralidoxime chloride | INJECTABLE;INTRAMUSCULAR | 021175 | NDA | Meridian Medical Technologies, LLC | 11704-777 | 11704-777-01 | 1 KIT in 1 CARTON (11704-777-01) * .7 mL in 1 SYRINGE, GLASS * 2 mL in 1 SYRINGE, GLASS |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAMUSCULAR | Strength | 2.1MG/0.7ML;600MG/2ML | ||||
| Approval Date: | Jan 17, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
